CryptoDuck

@TheMoonCarl That's just your own delusion.

$BTC is still in the Wyckoff distribution phase. Charts don't lie, people do.

@camelfinance That’s right, back then, neither BlackRock nor STRC existed. ETFs and STRC have bought up the entire mining output for this year. The impact is even greater than that of a halving event.

Remember: Jan - March of 2022, bitcoin did a ~46% bear market rally. The 20k bounce is nice but for context that is ~33% thus far. 46% would take us to ~88k. Also, day 36 today. Heavily right trans for bitcoin would be 45-50.

@0xbeehive Hey, back in 2018, it didn't even come close to the MA 350.

$BTC TRENDLINE BREAK CHANGES NOTHING In 2022 the setup was identical Months of downtrend, then a trendline break that looked like the real reversal It wasn't - just a liquidity trap before the continuation The cycle only ended when price touched MA 350 MA 350 is at $46k right now Until we see that touch, I'm not changing my bias FOLLOW + NOTIFS ON!

@jasonpizzino Hey, it's 2026 now. There's a BlackRock ETF.

Imagine arguing whether Bitcoin is in a bull or a bear market for another 7 months after it collapses over 50% in a short period of time. Well, that what we all did in 2018 after Bitcoin crashed 70% to find its base within 8 weeks. Plenty of emotion on the rallies, each one failing to cross the prior high. I've said many times that the tide is turning (the transition is approaching), but the trend is still down. Confirmation is key. (btw, at the end of the ~7 months of arguing, BTC collapsed another 50% in 2018...)

Current Bitcoin Status The price is rising. Trading volume continues to decline. The proportion of leveraged Open Interest (OI) continues to increase. These are classic signals of a distribution phase—a period in which major players are offloading their holdings.

@ChartNerdTA The problem is, everyone knows this right now.

If history continues to repeat, #Bitcoin bottoms exactly 1 year from its cycle top = October 2026 🎯

@MMCrypto Raise the line higher.

Bitcoin: If the Daily closes above resistance we may be golden!

@TheBTCTherapist However, the obligation to pay high dividends continues to grow. You need to properly explain both sides of the issue.

Michael Saylor is not diluting the common stock $MSTR to buy Bitcoin because he knows that $STRC will allow him to buy billions of dollars in Bitcoin over the next 2 weeks. Less dilution of MSTR means higher demand for shares which means higher prices while still buying Bitcoin.

@cantonmeow Don't just draw lines arbitrarily like that, lol.

@UnderCoercion Who is a liar but he that denieth that Jesus is the Christ? He is antichrist, that denieth the Father and the Son. Whosoever denieth the Son, the same hath not the Father: he that acknowledgeth the Son hath the Father also.

Vivek: Jesus is A son of god but Jesus is not THE son of god. Jesus is A way to heaven but not THE way to heaven.

Uranium Enrichment Levels and Their Uses Classification by enrichment level: Natural uranium (~0.7% U-235): Used in some reactors without further processing (e.g., CANDU reactors) Low-enriched uranium (LEU, 3–5%): Fuel for commercial nuclear power plants Below 20%: Research reactors, some medical isotope production 60% enrichment: Considered an intermediate stage toward nuclear weapons development — there is no legitimate civilian energy or research purpose at this level 90%+ (HEU): Weapons-grade uranium Enrichment level for energy (power generation) purposes: 3–5% is sufficient. 60% enriched uranium is a level explicitly tracked by the IAEA as an indicator of nuclear weapons development concerns. Accordingly, I won't provide technical details such as enrichment methods or processing procedures for this material.

BREAKING: Iran is no longer willing to negotiate over its nuclear program at all, per Tasnim. Discussions will only cover ending the war, sanctions relief, compensation, and lifting the blockade. Nuclear issues "could be addressed later in a separate agreement," only after the war has ended. Nuclear was the central issue in the first round of Islamabad talks, with Trump saying it was "the only point that really mattered." Iran has now removed it from the table entirely. Trump says the war won't end without a nuclear deal. Iran says nuclear won't be discussed until the war ends.

Uranium Enrichment Levels and Their Uses Classification by enrichment level: Natural uranium (~0.7% U-235): Used in some reactors without further processing (e.g., CANDU reactors) Low-enriched uranium (LEU, 3–5%): Fuel for commercial nuclear power plants Below 20%: Research reactors, some medical isotope production 60% enrichment: Considered an intermediate stage toward nuclear weapons development — there is no legitimate civilian energy or research purpose at this level 90%+ (HEU): Weapons-grade uranium Enrichment level for energy (power generation) purposes: 3–5% is sufficient. 60% enriched uranium is a level explicitly tracked by the IAEA as an indicator of nuclear weapons development concerns. Accordingly, I won't provide technical details such as enrichment methods or processing procedures for this material.

@HormuzLetter Iran already made it clear their nuclear program isn’t for weapons and harm, it’s simply energy. According to the west Irans been close to a nuclear weapon for 30 years now, people need to understand that the west is lying about this.

Analysis of Clavicular's Claims About Increlex/IGF-1 Claim 1: "It's a $180,000/month drug, only accessible to Elon Musk-tier billionaires" ⚠️ Misleading The price figure is roughly in the ballpark, but the context is completely distorted. According to CADTH (Canada's official drug assessment agency), Increlex is priced at $147.92 per mg ($5,916.64 per 40mg vial), and the annual cost based on the recommended dosage ranges from $65,083 to $183,416 for a 14.1kg patient, going up to $455,581 annually for a 35kg patient at maximum dose. In other words, it's up to ~$180,000 per year, not per month. Clavicular inflated annual cost into monthly cost — a 10x+ exaggeration, whether from misremembering or sensationalizing. More importantly: "Only billionaires can access it" is false. Patient assistance programs like Prescription Hope can obtain it for $70/month, and the manufacturer Eton Pharmaceuticals runs its own program, and eligible commercially insured patients may pay as little as $0 per prescription through copay cards. The reason it's expensive isn't "Big Pharma gatekeeping" — it's that this is an ultra-rare disease drug. Primary IGFD affects an estimated 30,000 children evaluated for short stature in the United States, and only a tiny subset of those meet the "severe" criteria. Small market = high per-unit price. This is standard orphan drug economics, not a conspiracy. Claim 2: "This is the best thing you can do because you're not interfering with your endocrine system" ❌ Flatly wrong This is genuinely dangerous misinformation. IGF-1 is a core component of the endocrine system. The entire GH–IGF-1 axis is endocrinology. From Increlex's official FDA labeling: Contraindications include hypersensitivity to mecasermin, intravenous administration, closed epiphyses, and malignant neoplasia; the most common adverse reactions are hypoglycemia, local and systemic hypersensitivity, and tonsillar hypertrophy Serious side effects can include tumor growth, low blood sugar, allergic reactions, increased pressure in the brain, enlarged tonsils, slipped capital femoral epiphysis, worsened scoliosis, and benzyl alcohol toxicity Some children who took Increlex developed cancer; while causation isn't confirmed, the risk increases with higher-than-recommended doses Exogenous IGF-1 administration suppresses endogenous GH secretion via negative feedback. The claim that it "doesn't interfere with your endocrine system" is physiologically incoherent. Claim 3: "IGF is one of the best growth pathways for getting more size" ⚠️ Partially true, but hides the risks It does play a role in muscle growth, but the context is stripped out. IGF-1 doesn't exclusively target muscle tissue; studies show that increases in IGF-1 stimulate both muscle and fat cell growth, and extended use of recombinant IGF-1 leads to tolerance via anti-IGF-1 antibodies, requiring progressively higher doses IGF-1 is a dichotomous hormone — beneficial for growth, repair, and muscle hypertrophy, but high concentrations are associated with increased risk of cancer and mortality A study of nearly 400,000 people confirmed that higher blood levels of IGF-1 are a risk factor for several types of cancer Long-term use without medical supervision risks acromegaly, organ enlargement, heart problems, and organ failure Overall Assessment Clavicular's claims follow the classic pattern of sensational framing + factual distortion + minimized safety concerns: Price inflation: Presenting the annual maximum as a monthly cost (10x+ overstatement) Conspiratorial framing: "Big Pharma gatekeeping" → actually an orphan drug with patient assistance programs that bring it to $0–$70/month for eligible patients Dangerous false safety claim: "Doesn't interfere with endocrine system" → IGF-1 is the endocrine system, and the drug carries risks of cancer, hypoglycemia, and acromegaly-like changes Implicit encouragement of off-label use: FDA approval is strictly for children 2+ with severe primary IGF-1 deficiency. Adult muscle enhancement is entirely off-label and not insurance-covered This is the narrative you typically see in bodybuilding/bro-science communities to justify underground peptide use (IGF-1 LR3, DES, etc.). Adults with closed growth plates cannot gain height from IGF-1 injections — longitudinal bone growth is physically impossible once epiphyses fuse. What you can gain: acromegalic features (enlarged jaw, hands, feet, organs), insulin resistance, and elevated cancer risk. The TL;DR: a legitimate pediatric orphan drug is being reframed as a secret billionaire biohack. It's neither secret nor a biohack — it's a niche pediatric endocrinology treatment with a serious side effect profile that was never designed for adult physique enhancement.

Clavicular says Big Pharma is gatekeeping a drug that costs $180,000 a month and only billionaires can access "There's a drug called Increlex, generic IGF-1, it's really only accessible by Elon Musk tier billionaires because it's so outrageously expensive.. we're talking $180,000 a month" "This is quite literally the best thing you could do because you're not actually interfering with your endocrine system" "IGF is one of the best growth pathways in terms of getting more size.. it's a really important hormone in your body"

@HormuzLetter It looks like Iran is being completely defeated.

BREAKING: Iran says it did not request a ceasefire extension and that "Trump has lost the war and knows he will gain nothing through it," per Tasnim. Ghalibaf's advisor says the extension "means nothing" as "the losing side cannot dictate terms," adding that the continuation of the blockade is "no different from bombardment" and must be met with a military response.

@Kalshi A 50% chance of being reached = A 50% chance of not being reached.

JUST IN: JPMorgan raises S&P 500 year-end target to 7,600 50% chance it hits

@Osint613 Trump has already been preparing for a ground war in Iran, and the peace talks are nothing more than a deception.

I really have no grasp on what’s happening with the U.S. Iran negotiations. Do you? If yes, please try to explain it to me.

@nicrypto I hope so.

@IamCryptoDuck I don't think that's what happening mate.

If the previous Iran nuclear deal took 3 years to negotiate, why is the market pricing in a quick deal / resolution now?

맛이란게 오묘한게, 계속 먹다보면 맛없는 것도 맛있어지기 시작해요. 예를 들어 어느 나라나 다른 나라 사람들은 절대 먹지 못하는 독특한 맛의 음식들이 있죠. 그 나라 사람들은 어릴 때부터 그걸 계속 먹다보니 맛 느끼게 되는 거죠. 맥주도 계속 먹다 보면 맛있다고 느껴지는 순간이 와요. 그렇지 않나요

生まれて初めて飲むビールって多分人類全員「苦くて不味い」って思うと思うんだけど、なんで歴史上で淘汰されずに生き残り続けてるのかが謎すぎる、絶対オレンジジュースやコーラの方が美味い 有識者いらっしゃいますか

@TheRealPlanC Because the remaining 96% of Bitcoin holders are selling.

Anyone selling Bitcoin because they're convinced it's heading below $60K and the cycle low has to print in Q4 is just gifting their stack to Michael Saylor. The odds of him ever handing it back are near zero. How does price crash to $30K or $40K when Saylor is absorbing 10,000 to 30,000 BTC a week?